James T. Dalton

2009

In 2009, James T. Dalton earned a total compensation of $689.2K as Vice President, Preclinical Research and Development at GTX, a 9% increase compared to previous year.

Compensation breakdown

Option Awards$234,225
Salary$400,000
Other$54,940
Total$689,165

Dalton received $400K in salary, accounting for 58% of the total pay in 2009.

Dalton also received $234.2K in option awards and $54.9K in other compensation.

Rankings

In 2009, James T. Dalton's compensation ranked 5,743rd out of 9,885 executives tracked by ExecPay. In other words, Dalton earned more than 41.9% of executives.

ClassificationRankingPercentile
All
5,743
out of 9,885
42nd
Division
Manufacturing
2,068
out of 3,690
44th
Major group
Chemicals And Allied Products
438
out of 866
49th
Industry group
Drugs
285
out of 638
55th
Industry
Pharmaceutical Preparations
213
out of 446
52nd
Source: SEC filing on March 18, 2011.

Dalton's colleagues

We found four more compensation records of executives who worked with James T. Dalton at GTX in 2009.

2009

Mitchell FACS

GTX

Chief Executive Officer

2009

Marc Hanover

GTX

Chief Operating Officer

2009

Ronald FACS

GTX

Chief Medical Officer

2009

Mark Mosteller

GTX

Chief Financial Officer

You may also like